Partnering

Enara Bio® recognizes the value of collaborating with external experts from academia and industry to develop our science into novel therapeutics that will improve treatment outcomes for cancer patients.

We welcome enquiries about establishing new partnerships and collaborations, including joint efforts to expand our Dark Antigen® discovery research.

While our internal therapeutic focus is on T-cell engagers, our EDAPT® platform can also identify Dark Antigen targets for other treatment modalities, including ADCs, cell therapies and therapeutic vaccines.

Interested in partnering with us?
Contact us